Article ; Online: Leucine and branched-chain amino acid metabolism contribute to the growth of bone sarcomas by regulating AMPK and mTORC1 signaling.
2020 Volume 477, Issue 9, Page(s) 1579–1599
Abstract: Osteosarcoma and chondrosarcoma are sarcomas of the bone and the cartilage that are primarily treated by surgical intervention combined with high toxicity chemotherapy. In search of alternative metabolic approaches to address the challenges in treating ... ...
| Abstract | Osteosarcoma and chondrosarcoma are sarcomas of the bone and the cartilage that are primarily treated by surgical intervention combined with high toxicity chemotherapy. In search of alternative metabolic approaches to address the challenges in treating bone sarcomas, we assessed the growth dependence of these cancers on leucine, one of the branched-chain amino acids (BCAAs), and BCAA metabolism. Tumor biopsies from bone sarcoma patients revealed differential expression of BCAA metabolic enzymes. The cytosolic branched-chain aminotransferase (BCATc) that is commonly overexpressed in cancer cells, was down-regulated in chondrosarcoma (SW1353) in contrast with osteosarcoma (143B) cells that expressed both BCATc and its mitochondrial isoform BCATm. Treating SW1353 cells with gabapentin, a selective inhibitor of BCATc, further revealed that these cells failed to respond to gabapentin. Application of the structural analog of leucine, N-acetyl-leucine amide (NALA) to disrupt leucine uptake, indicated that all bone sarcoma cells used leucine to support their energy metabolism and biosynthetic demands. This was evident from the increased activity of the energy sensor AMP-activated protein kinase (AMPK), down-regulation of complex 1 of the mammalian target of rapamycin (mTORC1), and reduced cell viability in response to NALA. The observed changes were most profound in the 143B cells, which appeared highly dependent on cytosolic and mitochondrial BCAA metabolism. This study thus demonstrates that bone sarcomas rely on leucine and BCAA metabolism for energy and growth; however, the differential expression of BCAA enzymes and the presence of other carbon sources may dictate how efficiently these cancer cells take advantage of BCAA metabolism. |
|||||
|---|---|---|---|---|---|---|
| MeSH term(s) | AMP-Activated Protein Kinases/metabolism ; Amino Acids, Branched-Chain/metabolism ; Bone Neoplasms/metabolism ; Cell Line, Tumor ; Chondrosarcoma/metabolism ; Cytosol/metabolism ; Energy Metabolism ; Humans ; Leucine/metabolism ; Mechanistic Target of Rapamycin Complex 1/metabolism ; Mitochondria/metabolism ; Osteosarcoma/metabolism ; Signal Transduction ; TOR Serine-Threonine Kinases/metabolism ; Transaminases/metabolism | |||||
| Chemical Substances | Amino Acids, Branched-Chain ; Transaminases (EC 2.6.1.-) ; branched-chain-amino-acid transaminase (EC 2.6.1.42) ; TOR Serine-Threonine Kinases (EC 2.7.1.1) ; Mechanistic Target of Rapamycin Complex 1 (EC 2.7.11.1) ; AMP-Activated Protein Kinases (EC 2.7.11.31) ; Leucine (GMW67QNF9C) | |||||
| Language | English | |||||
| Publishing date | 2020-04-15 | |||||
| Publishing country | England | |||||
| Document type | Journal Article ; Research Support, Non-U.S. Gov't | |||||
| ZDB-ID | 2969-5 | |||||
| ISSN | 1470-8728 ; 0006-2936 ; 0306-3275 ; 0264-6021 | |||||
| ISSN (online) | 1470-8728 | |||||
| ISSN | 0006-2936 ; 0306-3275 ; 0264-6021 | |||||
| DOI | 10.1042/BCJ20190754 | |||||
| Shelf mark |
|
|||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Uc I Zs.110: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.